Abbott Laboratories (ABT) Gains from Investment Securities (2016)
Abbott Laboratories (ABT) reported Gains from Investment Securities of -$1.0 million for Q4 2016, down 125.0% sequentially from $4.0 million in Q3 2016.
Abbott Laboratories (ABT) Gains from Investment Securities (2016) Analysis & Trends
Abbott Laboratories (ABT) has 1 years of Gains from Investment Securities data on file, last reported at -$1.0 million in Q4 2016.
- For the quarter ending Q4 2016, Gains from Investment Securities changed N/A year-over-year to -$1.0 million; the trailing twelve-month figure through Dec 2016 stood at $480.0 million (changed N/A YoY), and the FY2016 full-year result was $480.0 million, changed N/A from the prior year.
- Gains from Investment Securities eased to -$1.0 million in Q4 2016, from $4.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $477.0 million in Q1 2016 to a low of -$1.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -1.00 Mn |
| Dec 31, 2016 | -1.00 Mn |
| Sep 30, 2016 | 4.00 Mn |
| Sep 30, 2016 | 4.00 Mn |
| Mar 31, 2016 | 477.00 Mn |
| Mar 31, 2016 | 477.00 Mn |